Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Rare disease

Facioscapulohumeral muscular dystrophy

  • 8 clinical trials
Quick filters

8 Clinical trials

Facioscapulohumeral muscular dystrophy

Recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Humanised Igg1 Monoclonal Antibody Against Tfr1 Conjugated To Double Stranded Sirna Oligonucleotide Against Dux4 Mrna Via A Non-Cleavable Linker
  • Sponsor:Avidity Biosciences Inc.

Facioscapulohumeral muscular dystrophy

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ads-010
  • Sponsor:Sarepta Therapeutics Inc.

Facioscapulohumeral muscular dystrophy

Not recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Losmapimod
  • Sponsor:Fulcrum Therapeutics Inc.

Facioscapulohumeral muscular dystrophy

Not recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Humanised Igg1 Monoclonal Antibody Against Human Latent Myostatin
  • Sponsor:F. Hoffmann-La Roche AG

Facioscapulohumeral muscular dystrophy

Not recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Losmapimod
  • Sponsor:Fulcrum Therapeutics Inc.

Facioscapulohumeral muscular dystrophy

Not recruiting
InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Losmapimod
  • Sponsor:Fulcrum Therapeutics Inc.
See all trials →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.